Development and potential clinical uses of human prolactin receptor antagonists

V Goffin, S Bernichtein, P Touraine… - Endocrine …, 2005 - academic.oup.com
There is a large body of literature showing that prolactin (PRL) exerts growth-promoting
activities in breast cancer, and possibly in prostate cancer and prostate hyperplasia. In …

Model for growth hormone receptor activation based on subunit rotation within a receptor dimer

RJ Brown, JJ Adams, RA Pelekanos, Y Wan… - Nature structural & …, 2005 - nature.com
Growth hormone is believed to activate the growth hormone receptor (GHR) by dimerizing
two identical receptor subunits, leading to activation of JAK2 kinase associated with the …

Monoclonal antibody-based quantitation of poly (ethylene glycol)-derivatized proteins, liposomes, and nanoparticles

TL Cheng, CM Cheng, BM Chen, DA Tsao… - Bioconjugate …, 2005 - ACS Publications
Covalent attachment of poly (ethylene glycol)(PEG) molecules to drugs, proteins, and
liposomes is a proven technology for improving their bioavailability, safety, and efficacy …

Pharmacologic therapies for acromegaly: a review of their effects on glucose metabolism and insulin resistance

AM Pereira, NR Biermasz, F Roelfsema… - Treatments in …, 2005 - Springer
Acromegaly is associated with insulin resistance and an increased incidence of
cardiovascular disease. However, it remains unclear to what extent the effects of growth …

Hormonal regulation of liver cytochrome P450 enzymes

DJ Waxman, TKH Chang - Cytochrome P450: structure, mechanism, and …, 2005 - Springer
Sex differences in hepatic drug metabolism have been known for more than 30 years, based
on the early studies of Kato, Conney, Gillette, and others^~^. In rats and certain other …

[图书][B] Acromegaly: pathology, diagnosis and treatment

AJ Van der Lely, A Beckers, A Daly, SW Lamberts… - 2005 - taylorfrancis.com
This book reviews the pathophysiology and physical manifestations of acromegaly and
discusses the multiple treatment options now available for the management of the patient …

Treatment strategies for acromegaly

F Roelfsema, NR Biermasz, JA Romijn… - Expert opinion on …, 2005 - Taylor & Francis
Acromegaly is a chronic debilitating disorder caused by a growth hormone (GH)-producing
pituitary adenoma. Active acromegaly is associated with a two-to fourfold increased mortality …

Emerging drugs for diabetic nephropathy

S Bruno, D Cattaneo, N Perico… - Expert opinion on …, 2005 - Taylor & Francis
There is an increasing number of patients with diabetes mellitus in many countries. Diabetic
kidney disease, one of its microvascular complications, is also increasing markedly and has …

Growth hormone binding proteins

G Baumann - The endocrine system in sports and exercise, 2005 - Wiley Online Library
outside the plasma membrane (Wang et al. 2002). Based on the sequence similarity of the
rabbit and human GHRs in the extracellular stem region, it appears likely that the human …